Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
0.2051
+0.0039 (1.94%)
Jun 5, 2025, 4:00 PM - Market closed

Catheter Precision Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.480.420.440.010.020.26
Revenue Growth (YoY)
9.57%-4.98%3057.14%-36.36%-91.51%-
Cost of Revenue
0.050.040.030.161.562.17
Gross Profit
0.430.380.41-0.15-1.54-1.91
Selling, General & Admin
12.1811.3517.1216.2515.4824.53
Research & Development
0.460.270.486.3912.258.96
Operating Expenses
12.6411.6217.622.6427.7333.49
Operating Income
-12.2-11.24-17.19-22.79-29.27-35.4
Interest Expense
-0.14-0.09----
Interest & Investment Income
0.070.080.35---
Other Non Operating Income (Expenses)
-3.32-2.257.20.1-0.010.09
EBT Excluding Unusual Items
-15.6-13.5-9.64-22.69-29.28-35.31
Merger & Restructuring Charges
----4.17--
Impairment of Goodwill
---60.93---
Other Unusual Items
----2.02-
Pretax Income
-15.6-13.5-70.57-26.86-27.26-35.31
Income Tax Expense
2.423.14-000.01
Earnings From Continuing Operations
-18.01-16.64-70.57-26.87-27.26-35.32
Earnings From Discontinued Operations
----2.19-0.73
Net Income
-18.01-16.64-70.57-26.87-25.07-36.05
Preferred Dividends & Other Adjustments
5.165.160.8---
Net Income to Common
-23.17-21.8-71.37-26.87-25.07-36.05
Shares Outstanding (Basic)
63100-
Shares Outstanding (Diluted)
63100-
Shares Change (YoY)
784.28%493.91%431.53%923.58%--
EPS (Basic)
-3.93-6.68-129.88-259.86-2482.18-
EPS (Diluted)
-3.93-6.68-129.88-259.86-2482.18-
Free Cash Flow
-9.72-9.34-20.7-22.59-27.89-28.37
Free Cash Flow Per Share
-1.65-2.86-37.66-218.46-2761.39-
Gross Margin
90.02%90.00%93.21%---
Operating Margin
-2536.80%-2676.91%-3888.01%-162778.57%-133027.27%-13668.34%
Profit Margin
-4817.26%-5190.71%-16147.51%-191892.86%-113954.55%-13916.99%
Free Cash Flow Margin
-2021.21%-2223.33%-4682.13%-161321.43%-126772.73%-10954.05%
EBITDA
-10.08-9.13-15.11-22.37-28.1-33.44
D&A For EBITDA
2.122.112.080.421.171.97
EBIT
-12.2-11.24-17.19-22.79-29.27-35.4
Revenue as Reported
-----0.26
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q